Clinical trial
Effect of Fully Blocking Type 1 Angiotensin Receptor on Blood Pressure, Cardiac Structure, Cardiac Function and Cognitive Function in Postmenopausal Hypertensive Women
NCT03432468 is registered in ClinicalTrials.gov with LanZhou University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Fully Blocking Type 1 Angiotensin Receptor on Blood Pressure, Cardiac Structure, Cardiac Function and Cognitive Function in Postmenopausal Hypertensive Women
- Lead sponsor
- LanZhou University
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- April 1, 2018
- Completion date
- August 1, 2019
- Enrollment
- 102 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.